A human cytotoxic T-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of MUC-1

Details for Australian Patent Application No. 2011203056 (hide)

Owner Government of the United States of America, as represented by the Secretary of the Department of Health and Human Services National Institutes of Health

Inventors Schlom, Jeffrey; Tsang, Kwong-Yok

Agent Pizzeys

Pub. Number AU-A-2011203056

Parent 2004299457

Filing date 23 June 2011

Wipo publication date 14 July 2011

International Classifications

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 14/47 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

G01N 33/567 (2006.01) Investigating or analysing materials by specific methods not covered by groups - utilising isolate of tissue or organ as binding agent

Event Publications

7 July 2011 Complete Application Filed

14 July 2011 Application Open to Public Inspection

  Published as AU-A-2011203056

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203057-Muteins of tear lipocalin and methods for obtaining the same

2011203055-Hybrid induction balance/pulse induction metal detector